Ligand Pharmaceuticals Inc (LGND)
71.24
+0.87
(+1.24%)
USD |
NASDAQ |
Apr 26, 13:52
Ligand Pharmaceuticals Price: 71.24 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 70.24 | 71.16 | 69.63 | 70.37 | 105902.0 |
Apr 24, 2024 | 69.46 | 71.00 | 69.16 | 71.00 | 152955.0 |
Apr 23, 2024 | 68.50 | 71.16 | 68.50 | 69.89 | 140672.0 |
Apr 22, 2024 | 72.98 | 72.98 | 67.72 | 68.53 | 247324.0 |
Apr 19, 2024 | 71.93 | 72.95 | 71.16 | 72.47 | 137196.0 |
Apr 18, 2024 | 78.70 | 78.70 | 72.50 | 72.52 | 131220.0 |
Apr 17, 2024 | 79.92 | 80.53 | 78.30 | 78.87 | 179844.0 |
Apr 16, 2024 | 79.47 | 81.52 | 79.06 | 79.92 | 158485.0 |
Apr 15, 2024 | 80.81 | 80.96 | 79.09 | 79.77 | 175640.0 |
Apr 12, 2024 | 81.48 | 81.73 | 80.43 | 81.36 | 171376.0 |
Apr 11, 2024 | 81.42 | 81.56 | 80.58 | 81.43 | 147248.0 |
Apr 10, 2024 | 79.63 | 81.04 | 78.88 | 80.78 | 146147.0 |
Apr 09, 2024 | 79.46 | 81.64 | 78.89 | 81.50 | 142118.0 |
Apr 08, 2024 | 77.49 | 80.21 | 77.48 | 79.60 | 160954.0 |
Apr 05, 2024 | 77.45 | 78.35 | 76.02 | 77.96 | 165690.0 |
Apr 04, 2024 | 78.01 | 78.87 | 76.92 | 77.98 | 311838.0 |
Apr 03, 2024 | 72.60 | 74.88 | 72.51 | 74.73 | 102027.0 |
Apr 02, 2024 | 73.20 | 73.35 | 72.30 | 73.21 | 122828.0 |
Apr 01, 2024 | 73.35 | 73.62 | 71.22 | 73.60 | 181067.0 |
Mar 28, 2024 | 71.29 | 73.42 | 71.12 | 73.10 | 109733.0 |
Mar 27, 2024 | 69.26 | 71.85 | 68.80 | 71.27 | 191807.0 |
Mar 26, 2024 | 69.82 | 70.25 | 68.24 | 68.64 | 107915.0 |
Mar 25, 2024 | 71.38 | 71.68 | 68.98 | 69.25 | 107055.0 |
Mar 22, 2024 | 72.91 | 72.91 | 71.00 | 71.00 | 67489.00 |
Mar 21, 2024 | 73.74 | 73.88 | 72.42 | 72.96 | 91154.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
49.57
Minimum
Oct 27 2023
215.83
Maximum
Feb 09 2021
99.26
Average
96.82
Median
Price Benchmarks
ANI Pharmaceuticals Inc | 65.46 |
ADMA Biologics Inc | 6.575 |
Viking Therapeutics Inc | 71.45 |
Corcept Therapeutics Inc | 23.09 |
Palatin Technologies Inc | 1.72 |
Price Related Metrics
PE Ratio | 24.57 |
PS Ratio | 9.597 |
Price to Book Value | 1.800 |
Earnings Yield | 4.07% |
Market Cap | 1.261B |
Operating PE Ratio | 128.32 |
Normalized PE Ratio | 77.26 |